222 related articles for article (PubMed ID: 6172671)
1. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
Fitz AE; Saunders E
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of hypertension with methyldopa. VIII. Overview.
Itskovitz HD
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of hypertension with methyldopa. I. Study objectives and design.
Itskovitz HD; Menduke H
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S79-84. PubMed ID: 6172670
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
del Greco F; Huang CM; Quintanilla A
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
[TBL] [Abstract][Full Text] [Related]
5. Metolazone in essential hypertension: the long-term clinical efficacy of a new diuretic.
Dornfeld L; Kane RE
Curr Ther Res Clin Exp; 1975 Oct; 18(4):527-33. PubMed ID: 810314
[No Abstract] [Full Text] [Related]
6. Long-term treatment of hypertension with methyldopa. III. Tolerability.
Caldwell JR; Metts JC
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
Karachalios GN
Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of hypertensive with methyldopa. VI. Patient with target organ disease.
Brest AN
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S109-13. PubMed ID: 6172666
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of hypertension with methyldopa. A retrospective multiclinic study.
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S75-127. PubMed ID: 6172669
[No Abstract] [Full Text] [Related]
10. Sodium and fluid balance during hypotensive response to alpha-methyldopa.
Birkenhäger WH; de Leeuw PW; Geerling J; Statius van Eps LW
Clin Exp Pharmacol Physiol Suppl; 1978; 4():43-9. PubMed ID: 354828
[TBL] [Abstract][Full Text] [Related]
11. Methyldopa: single daily dose versus multiple daily dose.
Yang C; Gurwich E; Kanada S; Nascimento L
Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
Fernandez PG; Zachariah PK; Bryant DG; Missan SS
Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
[TBL] [Abstract][Full Text] [Related]
13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
14. [Alphamethyldopa vs. atenolol in the treatment of arterial hypertension].
Magalhães LB; Guimarães AC
Arq Bras Cardiol; 1986 Jun; 46(6):431-6. PubMed ID: 3555425
[No Abstract] [Full Text] [Related]
15. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
Vaicaitis JS
Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
[TBL] [Abstract][Full Text] [Related]
17. [Methyldopa in the therapy of hypertension].
Hilden T; Nilsson R
Tidsskr Nor Laegeforen; 1968 Jul; 88(14):1416-20. PubMed ID: 5699219
[No Abstract] [Full Text] [Related]
18. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
[TBL] [Abstract][Full Text] [Related]
19. The long-term effectiveness of methyldopa in hypertension.
Okun R; Roth SE; Gordon A; Maxwell MH
Calif Med; 1966 Jan; 104(1):46-50. PubMed ID: 5909253
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
Brahm M
Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
